Injectable formulation of Busulfan: Received FDA clearance for a Phase I trial in 20 patients. Additional funding is being sought before the trial can begin. Th

Sparta Pharmaceuticals Inc. (SPTA), Research Triangle Park, N.C. Product: Injectable formulation of Busulfan, in Spartaject lipid-based delivery system Indication: Chronic leukemia and preparative che...